European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 141, Issue 2 , Pages 131-136 , December 2008

The effect of mifepristone on apoptosis and caspase-3 activation in human ovarian luteinized granulosa cells

Received 24 May 2007 ,Revised 17 April 2008 ,Accepted 4 July 2008.

References 

  1. Gemzell-Danielsson K, Mandl I, Marions L. Mechanisms of action of mifepristone when used for emergency contraception. Contraception. 2003;68:471–476
  2. Sengupta J, Dhawan L, Lalitkumar PGL, Ghosh D. A multiparametric study of the action of mifepristone used in emergency contraception using the Rhesus monkey as a primate model. Contraception. 2003;68:453–469
  3. von Hertzen H, Piaggio G, Ding J, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet. 2002;360:1803–1810
  4. Chabbert-Buffet N, Meduri G, Bouchard P, Spitz IM. Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications. Human Reproduction Update. 2005;11:293–307
  5. Sarkar NN. The potential of mifepristone (RU486) as a female contraceptive drug. International Journal of Clinical Practice. 2002;56:140–144
  6. Brown A, Cheng L, Lin S, Baird D. Daily low-dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: a double-blind randomized control trial of 2 and 5mg per day for 120 days. Journal of Clinical Endocrinology Metabolism. 2002;87:63–70
  7. Godfrey EM, Mawson JT, Stanwood NL, Fielding SL, Schaff EA. Low-dose mifepristone for contraception: a weekly versus planned postcoital randomized pilot study. Contraception. 2004;70:41–46
  8. Duerrschmidt N, Zabirnyk O, Nowicki M, et al. LOX-1 receptor mediated autophagy in human granulosa cells as an alternative of programmed cell death. Endocrinology. 2006;147:3851–3860
  9. Rung E, Friberg PA, Bergh C, Billig H. Depletion of substrates for protein prenylation increases apoptosis in human periovulatory granulosa cells. Molecular Reproduction and Development. 2006;73:1277–1283
  10. Hamm ML, Bhat GK, Thompson WE, Mann DR. Folliculogenesis is impaired and granulosa cell apoptosis is increased in leptin-deficient mice. Biology of Reproduction. 2004;71:66–72
  11. Moffatt-Blue CS, Sury JJ, Young KA. Short photoperiod-induced ovarian regression is mediated by apoptosis in Siberian hamsters (Phodopus sungorus). Reproduction. 2006;131:771–782
  12. Chen Q, Yano T, Matsumi H, et al. Cross-talk between fas/fas ligand system and nitric oxide in the pathway subserving granulosa cell apoptosis: a possible regulatory mechanism for ovarian follicle atresia. Endocrinology. 2005;146:808–815
  13. Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407:770–776
  14. Matikainen T, Perez GI, Zheng TS, et al. Caspase-3 gene knockout defines cell lineage specificity for programmed cell death signaling in the ovary. Endocrinology. 2001;142:2468–2480
  15. Reed JC. Mechanisms of apoptosis. American Journal of Pathology. 2000;157:1415–1430
  16. Valdez KE, Cuneo SP, Turzillo AM. Regulation of apoptosis in the atresia of dominant bovine follicles of the first follicular wave following ovulation. Reproduction. 2005;130:71–81
  17. Rung E, Friberg PA, Shao R, et al. Progesterone-receptor antagonists and statins decrease de novo cholesterol synthesis and increase apoptosis in rat and human periovulatory granulosa cells in vitro. Biology of Reproduction. 2005;72:538–545
  18. Makino A, Ozaki Y, Matsubara H, et al. Role of apoptosis controlled by cytochrome c released from mitochondria for luteal function in human granulosa cells. American Journal of Reproductive Immunology. 2005;53:144–152
  19. Vitale AM, Abramovich D, Peluffo MC, Meresman G, Tesone M. Effect of gonadotropin-releasing hormone agonist and antagonist on proliferation and apoptosis of human luteinized granulosa cells. Fertility and Sterility. 2006;85:1064–1067
  20. Orisaka M, Orisaka S, Jiang JY, et al. Growth differentiation factor 9 is antiapoptotic during follicular development from preantral to early antral stage. Molecular Endocrinology. 2006;20:2456–2468
  21. Shin SY, Lee JY, Lee E, et al. Protective effect of vascular endothelial growth factor (VEGF) in frozen-thawed granulosa cells is mediated by inhibition of apoptosis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2006;125:233–238
  22. Nicholas B, Alberio R, Fouladi-Nashta AA, Webb R. Relationship between low-molecular-weight insulin-like growth factor-binding proteins, caspase-3 activity, and oocyte quality. Biology of Reproduction. 2005;72:796–804
  23. Feranil J, Isobe N, Nakao T. Apoptosis in the antral follicles of swamp buffalo and cattle ovary: TUNEL and caspase-3 histochemistry. Reproduction in Domestic Animals. 2005;40:111–116
  24. Tsai NM, Hsieh RH, Au HK, Shieh MJ, Huang SY, Tzeng CR. Effects of gonadotrophin-releasing hormone agonists on apoptosis of granulosa cells. Annals of New York Academy Science. 2005;1042:531–537
  25. Berardinelli P, Russo V, Martelli A, et al. Colocalization of DNA fragmentation and caspase-3 activation during atresia in pig antral follicles. Anatomia Histologia Embryologia-Zentralblatt fur Veterinarmedizin Reihe. 2004;33:23–27
  26. Robbles R, Tao XJ, Trbovich AM, et al. Localization, regulation and possible consequences of apoptotic protease-activating factor-1 (Apaf-1) expression in granulosa cells of the mouse ovary. Endocrinology. 1999;140:2641–2644
  27. Boone DL, Tsang BK. Caspase-3 in the rat ovary: localization and possible role in follicular atresia and luteal regression. Biology of Reproduction. 1998;58:1533–1539
  28. Zeleznik AJ, Ihrig LL, Basset SG. Development expression of Ca2+/Mg2+-dependent endonuclease activity in rat granulosa and luteal cells. Endocrinology. 1989;125:2218–2220
  29. Fenwick MA, Hurst PR. Immunohistochemical localization of active caspase-3 in the mouse ovary: growth and atresia of small follicles. Reproduction. 2002;124:659–665
  30. El Etreby MF, Liang Y, Johnson MH, Lewis RW. Antitumor activity of mifepristone in the human LNCaP, LNCaP-C4, and LNCaP-C4-2 prostate cancer models in nude mice. Prostate. 2000;42:99–106
  31. Kamradt MC, Mohideen N, Vaughan AT. RU486 increases radiosensitivity and restores apoptosis through modulation of HPV E6/E7 in dexamethasone-treated cervical carcinoma cells. Gynecological Oncology. 2000;77:177–182
  32. Schneider CC, Gibb RK, Taylor DD, Wan T, Gercel-Taylor C. Inhibition of endometrial cancer cell lines by mifepristone (RU 486). Journal of the Society for Gynecologic Investigation. 1998;5:334–338
  33. Prange-Kiel J, Rune GM, Wallwiener D, Kiesel L. Inhibition of proliferation and differentiation by RU 486 in human endometrial stromal and epithelial cells in vitro. Experimental Clinical Endocrinology Diabetes. 2000;108:275–281
  34. Neulen J, Williams RF, Hodgen GD. RU486 (mifepristone): induction of dose-dependent elevations of estradiol receptor in endometrium from ovariectomized monkeys. Journal of Clinical Endocrinology Metabolism. 1990;71:1074–1075
  35. Li A, Felix JC, Minoo P, Amezcua CA, Jain JK. Effect of mifepristone on proliferation and apoptosis of Ishikawa endometrial adenocarcinoma cells. Fertility and Sterility. 2005;84:202–211
  36. Han S, Sidell N. RU486-induced growth inhibition of human endometrial cells involves the nuclear factor-kappa B signaling pathway. Journal of Clinical Endocrinology Metabolism. 2003;88:713–719
  37. Svensson EC, Markstrom E, Shao R, Andersson M, Billig H. Progesterone receptor antagonists Org31710 and RU486 increase apoptosis in human periovulatory granulosa cells. Fertility and Sterility. 2001;76:1225–1231

PII: S0301-2115(08)00299-6

doi: 10.1016/j.ejogrb.2008.07.031

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 141, Issue 2 , Pages 131-136 , December 2008

Article Tools

* Image Usage & Resolution